Skip to main content
Clinical Trials/DRKS00031523
DRKS00031523
Recruiting
Not Applicable

rheumatoid arthritis: observation of biologics treatment - RABBIT

Deutsches Rheuma-Forschungszentrum Berlin0 sites30,000 target enrollmentDecember 7, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
M05
Sponsor
Deutsches Rheuma-Forschungszentrum Berlin
Enrollment
30000
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 7, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Deutsches Rheuma-Forschungszentrum Berlin

Eligibility Criteria

Inclusion Criteria

  • Confirmed diagnosis of rheumatoid arthritis
  • \- At least 18 years of age at inclusion
  • \- Onset of rheumatoid arthritis after 16 years of age
  • \- Starting new therapy with an approved bDMARD (biologic Disease Modifying Anti\-Rheumatic Drug) or tsDMARD (targeted synthetic Disease Modifying Anti\-Rheumatic Drug) respectively with a new csDMARD (conventional synthetic Disease Modifying Anti\-Rheumatic Drug) after at least one csDMARD failure or addition of a csDMARD to an existing basic therapy

Exclusion Criteria

  • Patients with arthritis in the context of another autoimmune disease in the foreground, such as collagenosis or vasculitis

Outcomes

Primary Outcomes

Not specified

Similar Trials